Literature DB >> 2918235

Mast cell changes in a case of rapidly progressive scleroderma-ultrastructural analysis.

H N Claman1.   

Abstract

A 63-year-old woman had rapidly progressive scleroderma and died 4 months after the clinical appearance of her illness. Extreme itching of the affected skin was prominent. Electron microscopic study of the clinically uninvolved skin showed mainly normal mast cells. Mast cells in clinically involved skin showed a wide morphologic spectrum including evidence of cellular activation. There was an increased amount of cytoplasm occupied by polysomes and mitochondria and less cytoplasm occupied by granules. Most granules were pale and swollen, suggesting active degranulation. In some cases it was difficult to distinguish a hyperactive mast cell with only a few granules remaining from a fibroblast which had acquired granules by transgranulation. This case illustrates the active participation of mast cells in acute scleroderma.

Entities:  

Mesh:

Year:  1989        PMID: 2918235     DOI: 10.1111/1523-1747.ep12276876

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Vascular leak is a central feature in the pathogenesis of systemic sclerosis.

Authors:  Tracy M Frech; Monica P Revelo; Stavros G Drakos; Maureen A Murtaugh; Boaz A Markewitz; Allen D Sawitzke; Dean Y Li
Journal:  J Rheumatol       Date:  2012-06-01       Impact factor: 4.666

2.  Autophagy is a key feature in the pathogenesis of systemic sclerosis.

Authors:  Tracy Frech; Ivana De Domenico; Maureen A Murtaugh; Monica P Revelo; Dean Y Li; Allen D Sawitzke; Stavros Drakos
Journal:  Rheumatol Int       Date:  2013-08-11       Impact factor: 2.631

3.  A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.

Authors:  Arnold E Postlethwaite; Weng Kee Wong; Philip Clements; Soumya Chatterjee; Barri J Fessler; Andrew H Kang; Joseph Korn; Maureen Mayes; Peter A Merkel; Jerry A Molitor; Larry Moreland; Naomi Rothfield; Robert W Simms; Edwin A Smith; Robert Spiera; Virginia Steen; Kenneth Warrington; Barbara White; Frederick Wigley; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2008-06

4.  Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice.

Authors:  Naotaka Shiota; Eiichi Kakizoe; Keiko Shimoura; Tetsuya Tanaka; Hideki Okunishi
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

Review 5.  Mast cells in the pathogenesis of fibrosis.

Authors:  Barry L Gruber
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

Review 6.  A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis.

Authors:  Traci A Wilgus; Sara Ud-Din; Ardeshir Bayat
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.